Fundraising Fox
Opticyte
Seattle, US · Founded 2016 · 9 employees on LinkedIn · 1 known investors
Find your way into Opticyte
Sign up to see every warm intro you have to Opticyte
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Opticyte team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.
Founders & leadership
Opticyte was founded in 2016 by Lori Arakaki.
LA
Lori ArakakiFounder · Chief Executive OfficerLori Arakaki is the founder of Opticyte and has a background in bioengineering, with research expertise in developing algorithms for measuring component concentrations in biological optical spectra.
RM
Robert MastersonNamed on SEC filing
KS
Kenneth SchenkmanNamed on SEC filing
LA
Lorilee ArakakiNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$72.3K disclosed across 1 of 2 rounds · 2017–2021
▶$72.3KraisedOct 2017 · 2 investors · BiotechnologyRule 506(b)
▶$72.3KraisedOct 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert MastersonExecutive Officer, Director, Promoter
- Kenneth SchenkmanExecutive Officer, Director, Promoter
- Lorilee ArakakiExecutive Officer, Director, Promoter
- Offering amount
- $2.3M
- Amount sold
- $72.3K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Triple Ring TechnologiesTriple Ring Technologies is a technology development and innovation partner that co-develops breakthrough products with corporates, government programs, and startups, sharing funding and risk through its Corporate Growth Lab. It focuses on areas including physics- and bio-based AI, diagnostics, lab tools, medical devices, surgical robotics, imaging, and biomanufacturing.
Companies working in the same space as Opticyte.
In the news
Frequently asked questions
- What does Opticyte do?
- Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.
- Who founded Opticyte?
- Opticyte was founded by Lori Arakaki in 2016.
- Who are Opticyte's investors?
- Opticyte's investors include Swan Venture Fund.
- How much funding has Opticyte raised?
- Opticyte has disclosed $72.3K raised across 1 of its 2 known rounds.
- Where is Opticyte headquartered?
- Opticyte is headquartered in Seattle, US.